New moms may soon get depression treatment at home, study finds

NCT ID NCT05059600

First seen Oct 31, 2025 · Last updated May 08, 2026 · Updated 25 times

Summary

This study looked at whether the drug ZULRESSO (brexanolone) can be safely given to women with postpartum depression in their own homes instead of a clinic. Fifty-two women took part, and researchers tracked side effects and whether the safety rules were followed. The goal was to make treatment more convenient without compromising safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sage Investigational Site

    Culver City, California, 90230, United States

  • Sage Investigational Site

    Miramar, Florida, 33029, United States

  • Sage Investigational Site

    Pompano Beach, Florida, 33060, United States

  • Sage Investigational Site

    New York, New York, 10036, United States

  • Sage Investigational Site

    League City, Texas, 77573, United States

  • Virtual Site (recruiting nationwide)

    Culver City, California, 90230, United States

Conditions

Explore the condition pages connected to this study.